Glenmark Pharma receives approval from USFDA for bacterial infection drug
The United States Food & Drug Administration (USFDA) has given its final approval to Glenmark Pharmaceuticals’ Clindamycin Hydrochloride capsules. The […]
Tags: Glenmark Pharma, USFDA
Glenmark Pharma launches anti-diabetes drug in India
Glenmark Pharma, a Drug major, has launched novel drug Remogliflozin in India, which will be beneficial to treat type-2 diabetes […]
Glenmark Pharma plans capital expense of $300 mn in three years
Pharma major Glenmark Pharmaceuticals has chalked out a $300 million capital expenditure plan for the next three years to fund […]
